Pandemic Treaty Offers Opportunity to Repair Fault Lines in COVID-19 Response – and Address Equity 09/11/2021 Kerry Cullinan An international pandemic treaty based on equity could be the antidote to current weaknesses and imbalances in the global response to COVID-19, according to a group of influential authors in a Lancet paper published on Tuesday. A number of the authors are associated with The Independent Panel for Pandemic Preparedness and Response chaired by Helen […] Continue reading -> Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Tobacco Industry ‘Used COVID-19’ to Influence Governments Especially in Switzerland, Index Finds 02/11/2021 Kerry Cullinan The tobacco industry used the COVID-19 pandemic to ingratiate itself with governments around the world and win concessions for their harmful products, according to a review of 80 countries analyzed in the Global Tobacco Industry Interference Index 2021, which was released on Tuesday. It wasn’t simply economically vulnerable countries that were susceptible to industry influence. […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
Pfizer Says New Anti-Viral Drug Combination Cuts Risks Of Serious COVID-19 By 89% 05/11/2021 Aishwarya Tendolkar Pfizer Friday announced that its experimental COVID-19 oral antiviral drug PAXLOVID™ reduced risks of hospitalization and death by 89% among patients who received the drug within the first three days of their illness. The company said it had stopped its Phase 2/3 trial on the drug owing to the success rate seen in an interim […] Continue reading -> Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Tobacco Industry ‘Used COVID-19’ to Influence Governments Especially in Switzerland, Index Finds 02/11/2021 Kerry Cullinan The tobacco industry used the COVID-19 pandemic to ingratiate itself with governments around the world and win concessions for their harmful products, according to a review of 80 countries analyzed in the Global Tobacco Industry Interference Index 2021, which was released on Tuesday. It wasn’t simply economically vulnerable countries that were susceptible to industry influence. […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
Europe’s Surging COVID-19 Cases Provide Lessons for Rest of World 04/11/2021 Kerry Cullinan Europe is now the epicentre of the COVID-19 pandemic and what it is experiencing now provides lessons for the rest of the world, according to World Health Organization (WHO) officials addressing a media briefing on Thursday. In addition, the lack of a systematic, multilateral approach to address this pandemic has only underscored the need for […] Continue reading -> As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Tobacco Industry ‘Used COVID-19’ to Influence Governments Especially in Switzerland, Index Finds 02/11/2021 Kerry Cullinan The tobacco industry used the COVID-19 pandemic to ingratiate itself with governments around the world and win concessions for their harmful products, according to a review of 80 countries analyzed in the Global Tobacco Industry Interference Index 2021, which was released on Tuesday. It wasn’t simply economically vulnerable countries that were susceptible to industry influence. […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
As Indonesia greenlights Novavax COVID-19 Vaccine, Company Expects More Countries to Follow 02/11/2021 Kerry Cullinan Indonesia has granted emergency use authorization (EUA) for the COVID-19 vaccine developed by Novavax, which will be made by the Serum Institute of India (SII) and sold under the brand name Covovax. “This marks the first regulatory authorization worldwide of a protein-based COVID-19 vaccine based on Phase 3 clinical data demonstrating efficacy and a favourable […] Continue reading -> Tobacco Industry ‘Used COVID-19’ to Influence Governments Especially in Switzerland, Index Finds 02/11/2021 Kerry Cullinan The tobacco industry used the COVID-19 pandemic to ingratiate itself with governments around the world and win concessions for their harmful products, according to a review of 80 countries analyzed in the Global Tobacco Industry Interference Index 2021, which was released on Tuesday. It wasn’t simply economically vulnerable countries that were susceptible to industry influence. […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
Tobacco Industry ‘Used COVID-19’ to Influence Governments Especially in Switzerland, Index Finds 02/11/2021 Kerry Cullinan The tobacco industry used the COVID-19 pandemic to ingratiate itself with governments around the world and win concessions for their harmful products, according to a review of 80 countries analyzed in the Global Tobacco Industry Interference Index 2021, which was released on Tuesday. It wasn’t simply economically vulnerable countries that were susceptible to industry influence. […] Continue reading -> Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
Global COVID-19 Deaths: 5 Million and Counting 02/11/2021 Raisa Santos More than 5 million people have officially died from COVID-19 less than two years into the global pandemic. COVID-19 is now the third leading cause of death, after heart disease and stroke. There have been 5,003,021 COVID-19 related deaths as of 1 November, according to the Johns Hopkins COVID-19 Dashboard. In the United States, 746,021 […] Continue reading -> G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
G20 Disappoints on COVID-19 and Climate Crisis, Setting Stage for Non-Action at COP26 01/11/2021 Kerry Cullinan There will be no airlifting of COVID-19 vaccines to poor countries struggling to get their immunisation figures into double digits. There are also no concrete plans for wealthy countries to make good on their earlier dose promises to COVAX by giving actual delivery dates. And, there is no date for wealthy countries to phase out […] Continue reading -> WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
WHO Asks G-20 for $23.4 Billion to Fund COVID Vaccines, Tests & Treatments – and 550 Million Vaccine Doses Immediately! 28/10/2021 Elaine Ruth Fletcher Ahead of a critical G20 meeting this weekend, WHO and its partners are asking the world’s leading industrialized nations to come up with another US$ 23.4 billion over the course of the coming year to address stark shortages in COVID vaccines, tests and treatments remain dismally low in Africa and other parts of the developing […] Continue reading -> Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
Game-Changing COVID-19 Oral Treatment Set To Become Widely Accessible in Low- and Middle-Income Countries Upon Regulatory Approval 27/10/2021 Elaine Ruth Fletcher A potentially game-changing antiviral treatment for COVID-19 that can be administered orally early on, and potentially head off much more serious cases, is set to be licensed for generic production in most low- and middle-income countries (LMICs), in an unprecedented breakthrough in access to a new COVID treatment. The historic deal, reached between the pharma […] Continue reading -> World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts
World Watches UK COVID-19 Surge, and Parts of Europe Enter ‘Fourth Wave’ 22/10/2021 Kerry Cullinan Amid soaring COVID-19 cases in the UK, the government is prioritising giving third booster shots to people as it banks on the country’s high COVID-19 vaccination rate being able to prevent severe illness and death. Over the past week, COVID-19 cases in the UK increased by almost 18% – with 52,000 new cases confirmed on Thursday […] Continue reading -> Posts navigation Older postsNewer posts